RoviSys Enhances Strategies in Regulated Industries, Promotes Chris Kulbago as Director

RoviSys Strengthens Focus on Regulated Industries

RoviSys, a well-regarded independent company specializing in diverse automation solutions—including process automation, building automation, and discrete manufacturing automation—has made a significant move to bolster its capabilities catering to regulated industries. This strategic advancement aligns with increasing regulatory demands experienced by pharmaceutical, biotechnology, and medical device manufacturers. The organization proudly announces the promotion of Chris Kulbago, Jr. to the position of Director of RoviSys Building Technologies, focusing on crucial sectors like Pharma, Biotech, and Food and Beverage manufacturing.

Chris Kulbago’s journey with RoviSys began in 2012 as a co-op, where he has steadily advanced in his career within the Building Technologies group since 2015. His recent promotion comes as a testament to his dedication and capability in driving business growth through strong customer relationships and impactful solutions, which play a critical role in ROI enhancement for clients. The President of RoviSys, Derek Drayer, acknowledged Chris's significant contributions, stating, “Chris has earned the trust of our customers by understanding what regulated manufacturers need from their facilities systems and delivering results that make a real impact.”

RoviSys's growth trajectory has seen a particularly strong presence in New England, especially in the Boston area. This region is historically known for its innovation in pharmaceuticals and biotechnology, allowing RoviSys to leverage established relationships with industry-leading manufacturers. The company's capabilities in facility systems integration are extending not just across North America, but also into Europe, Asia Pacific (APAC), and ongoing expansions into Latin America.

Expertise in mission-critical facilities and environmental control solutions places RoviSys at the forefront of supporting regulated manufacturing environments. The company provides scalable platforms aimed at enhancing reliability and compliance readiness, crucial elements for manufacturers navigating complex regulatory landscapes. Moreover, RoviSys delivers comprehensive validation services, including commissioning and qualification, paired with compliance documentation—considered essential practices across pharmaceutical, biotech, and life sciences fields. This commitment is reflected in the alignment with current Good Manufacturing Practices (cGMP) to minimize risks and maintain regulatory readiness effectively.

Backed by regional and local validation teams, RoviSys stands out by merging deep automation experience with established validation methodologies. This combination succeeds in ensuring operational efficiency while reducing risks associated with compliance failures, a critical aspect in regulated industries.

RoviSys remains firmly established as an independent systems integrator, embarking on a mission to support digital transformation and industrial networking. Their automation solutions touch various sectors including Pharmaceutical, Biotechnology, Medical Device, and many others like Food and Beverage, Chemicals, and even Water and Wastewater. RoviSys aims to bolster operational capabilities ranging from the plant floor to the top floor, emphasizing their commitment to trusted systems.

As RoviSys advances with leadership changes like the promotion of Chris Kulbago, it continues to refine its strategies for serving the nuanced needs of regulated industries, ensuring not only compliance but also the efficiency needed for sustainable growth in a demanding market landscape.